BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27100728)

  • 1. Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.
    Zakaria R; Platt-Higgins A; Rathi N; Crooks D; Brodbelt A; Chavredakis E; Lawson D; Jenkinson MD; Rudland PS
    Br J Cancer; 2016 May; 114(10):1101-8. PubMed ID: 27100728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of metastasis-inducing proteins in ectopic and matched eutopic endometrium of women with endometriosis: implications for the pathogenesis of endometriosis.
    Hapangama DK; Raju RS; Valentijn AJ; Barraclough D; Hart A; Turner MA; Platt-Higgins A; Barraclough R; Rudland PS
    Hum Reprod; 2012 Feb; 27(2):394-407. PubMed ID: 22147918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
    Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
    Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.
    Rudland PS; Platt-Higgins AM; Davies LM; de Silva Rudland S; Wilson JB; Aladwani A; Winstanley JH; Barraclough DL; Barraclough R; West CR; Jones NJ
    Am J Pathol; 2010 Jun; 176(6):2935-47. PubMed ID: 20363922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.
    Barraclough DL; Platt-Higgins A; de Silva Rudland S; Barraclough R; Winstanley J; West CR; Rudland PS
    Am J Pathol; 2009 Nov; 175(5):1848-57. PubMed ID: 19834055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.
    de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P
    Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin is a prognostic biomarker in non-small cell lung cancer.
    Rud AK; Boye K; Oijordsbakken M; Lund-Iversen M; Halvorsen AR; Solberg SK; Berge G; Helland A; Brustugun OT; Mælandsmo GM
    BMC Cancer; 2013 Nov; 13():540. PubMed ID: 24215488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
    Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
    BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.
    Rud AK; Lund-Iversen M; Berge G; Brustugun OT; Solberg SK; Mælandsmo GM; Boye K
    BMC Cancer; 2012 Aug; 12():333. PubMed ID: 22853000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
    Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
    Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
    Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
    Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma.
    Bandiera A; Melloni G; Freschi M; Giovanardi M; Carretta A; Borri A; Ciriaco P; Zannini P
    World J Surg; 2009 Jul; 33(7):1414-20. PubMed ID: 19365673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G
    Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of osteopontin expression in melanoma progression.
    Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
    Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
    Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
    Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
    Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
    Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
    Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.